Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:GRNA

GreenLight Biosciences (GRNA) Stock Price, News & Analysis

GreenLight Biosciences logo

About GreenLight Biosciences Stock (NASDAQ:GRNA)

Advanced Chart

Key Stats

Today's Range
$0.30
$0.30
50-Day Range
$0.30
$0.30
52-Week Range
$0.18
$5.90
Volume
732 shs
Average Volume
486,986 shs
Market Capitalization
$45.43 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

FUNR manufactures and sells all-natural juice beverages. Its products include pomegranate cranberry, wild berry and passion fruit-orange. The company was founded by Alex C. Procopio on July 22, 1980 and is headquartered in Las Vegas, NV.

Receive GRNA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GreenLight Biosciences and its competitors with MarketBeat's FREE daily newsletter.

GRNA Stock News Headlines

Greenlight Coupon Codes
Warning: “DOGE Collapse” imminent
Elon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week, President Trump promised to buy a Tesla to help support Musk in the face of a boycott against his company. But according to one research group, with connections to the Pentagon and the U.S. government, Elon's preparing to strike back in a much bigger way in the days ahead.
Greenlight Family Cash Card 2023 Review
See More Headlines

GRNA Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that GreenLight Biosciences investors own include Sangamo Therapeutics (SGMO), Anavex Life Sciences (AVXL), Abrdn Asia-Pacific Income Fund (FAX), MSP Recovery (LIFW), MSP Recovery (LIFW), Meta Platforms (META) and NVIDIA (NVDA).

Company Calendar

Today
5/04/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:GRNA
Fax
N/A
Employees
280
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-167,050,000.00
Net Margins
-1,521.00%
Pretax Margin
-1,510.44%

Debt

Sales & Book Value

Annual Sales
$10.20 million
Price / Cash Flow
N/A
Book Value
$0.32 per share
Price / Book
0.94

Miscellaneous

Free Float
105,722,000
Market Cap
$45.43 million
Optionable
Not Optionable
Beta
1.44
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:GRNA) was last updated on 5/4/2025 by MarketBeat.com Staff
From Our Partners